Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
meropenem or imipenem
DRUG
2 trials
Sponsors
Mahidol University
, Assistance Publique - Hôpitaux de Paris
Conditions
Drug Safety
Urinary Tract Infections
Phase 3
Temocillin Versus a Carbapenem as Initial Intravenous Treatment for ESBL Related Urinary Tract Infections
Completed
NCT03543436
Assistance Publique - Hôpitaux de Paris
Urinary Tract Infections
Start: 2019-01-04
End: 2020-12-14
Updated: 2025-11-20
Phase 4
Ertapenem Versus Meropenem/Imipenem for ESBL+ Gram-negative Infections
NCT01297842
Mahidol University
Drug Safety
Start: 2011-05-31
End: 2013-08-31
Target: 100
Updated: 2012-01-02
Related Papers
Efficacy and safety of de-escalation therapy to ertapenem for treatment of infections caused by extended-spectrum-β-lactamase-producing Enterobacteriaceae: an open-label randomized controlled trial.
2017-03-01
18 citations